• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Journal of Medical Sciences
  2. Vol 6 (3), 2006
  3. 410-415
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Journal of Medical Sciences

Year: 2006 | Volume: 6 | Issue: 3 | Page No.: 410-415
DOI: 10.3923/jms.2006.410.415

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 177

Authors


Y. Raji


O.A Osonuga


S.B Olaleye


K.I. Adedokun


O.S. Akinsomisoye


O.O Mewoyeka


Keywords


  • Chloroquine
  • mefloquine
  • sulphadoxine-pyrimethamine
  • male reproduction
  • in vivo
  • ex vivo
Research Article

Comparative Activities of Chloroquine, Mefloquine and Sulphadoxine-pyrimethamine on in vivo and ex vivo Male Reproductive Functions in Mammalian Models

Y. Raji, O.A Osonuga, S.B Olaleye, K.I. Adedokun, O.S. Akinsomisoye and O.O Mewoyeka
Comparative reproductive activities of chloroquine, mefloquine and sulphadoxine-pyrimethamine were explored in albino Wistar rats and semen from West African Dwarf Buck (WADB) with a view to elucidating the mechanism of action of these drugs on malereproduction. Five adult male rats were administered 0.5 mL distilled water and served as the control. Five rats each were administered orally chloroquine (10 mg kg -1 b.w.), mefloquine (10 mg kg -1 b.w.) and sulphadoxine-pyrimethamine (5 mg kg -1 b.w.) orally, for four weeks. Each group had it`s own recovery group. Sperm counts, motility and morphology were reduced in rats treated with these drugs in the order mefloquine (p<0.05)> chloroquine > sulphadoxine-pyrimethamine. There was an appreciable recovery in the motility of sperms in all recovery groups. Semen samples from WADB were extended separately with chloroquine, mefloquine and sulphadoxine-pyrimethamine. Extender 1 (first control) had no PENSTRIP (Penicillin and Streptomycin combination) while extender 2 (standard extender; second control) had PENSTRIP. Semen in extenders 3, 4 and 5 were treated with chloroquine, mefloquine and sulphadoxine-pyrimethamine, respectively. Spermatozoa progressive motility in these extenders examined under the microscope at 24 h for 5 days significantly reduced in mefloquine (p<0.01), slightly with chloroquine and unchanged with sulphadoxine-pyrimethamine. The pH of the extenders was significantly reduced in duration dependent manner in mefloquine while it remained unchanged with chloroquine and sulphadoxine-pyrimethamine. The results suggest the safety of sulphadoxine-pyrimethamine and chloroquine in preservation of semen ex vivo while the negative impact of mefloquine could reside within the testis or epididymis.
PDF Fulltext XML References Citation

How to cite this article

Y. Raji, O.A Osonuga, S.B Olaleye, K.I. Adedokun, O.S. Akinsomisoye and O.O Mewoyeka, 2006. Comparative Activities of Chloroquine, Mefloquine and Sulphadoxine-pyrimethamine on in vivo and ex vivo Male Reproductive Functions in Mammalian Models. Journal of Medical Sciences, 6: 410-415.

DOI: 10.3923/jms.2006.410.415

URL: https://scialert.net/abstract/?doi=jms.2006.410.415

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved